Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

June 20, 2022

Ginseng intake and mortality

Regular ginseng intake, particularly over a long duration, is associated with decreased risk of death from all causes, Vanderbilt researchers discovered in a large epidemiological study.

By Leigh MacMillan
June 16, 2022

Breast cancer biomarkers of response

Vanderbilt researchers have identified blood-based biomarkers associated with complete responses to neoadjuvant chemotherapy in patients with breast cancer.

By Joshua Baker
May 26, 2022

Conquer Cancer awards given to five hematology-oncology fellows

Five Vanderbilt University Medical Center hematology and oncology fellows will receive awards from Conquer Cancer, the ASCO Foundation, during the 2022 American Society of Clinical Oncology Annual Meeting in Chicago, June 3-7.

By Tom Wilemon
May 19, 2022

Clarksville cancer center has new name

The Vanderbilt-affiliated cancer center in Clarksville has a new name: Vanderbilt-Ingram Cancer Center at Tennova Healthcare – Clarksville (VICCTHC).

By VUMC News and Communications
May 10, 2022

Davis named section chief of Breast Imaging

Katie Davis, DO, assistant professor of Radiology, has been named section chief of Breast Imaging, a position she has held in an interim capacity since 2021.

By Krystyna Barnard
May 6, 2022

Janet Darnell received a lifesaving lung transplant. Five months later she received lifesaving surgery for colon cancer. She calls herself a “walking miracle.”

Without the lung transplant, the cancer may never have been detected.

By Matt Batcheldor
May 5, 2022

VICC Scientific Retreat focuses on lung cancer

By Tom Wilemon
April 28, 2022

Studies combine genetic testing, electronic health records to find undiagnosed diseases

Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.
By Leigh MacMillan
April 25, 2022

Molecular testing across tumor types

The KRAS inhibitor sotorasib is newly approved for one kind of lung cancer; Vanderbilt researchers ask if it should be considered for another type if the tumor has the gene mutation it targets.
By Leigh MacMillan
April 22, 2022

“Our family is forever grateful”: Latest DAISY Awards honor seven extraordinary nurses

DAISY Awards are given to great nurses all over the United States and in many other countries
By Matt Batcheldor
April 12, 2022

Financial impact of prior authorization

Prior authorization — health insurer approval of a medical intervention prior to treatment — costs more than $40 million for U.S. academic radiation oncology practices, with questionable value added to patient care.
By Leigh MacMillan
March 31, 2022

Clip In 4 the Cure

More than 300 riders participated in the inaugural Clip In 4 the Cure, a relay-style, team cycling event that supported cancer initiatives at Vanderbilt-Ingram Cancer Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt.
By VUMC News and Communications
March 31, 2022

Black patients with cancer face worse COVID outcomes: study

Vanderbilt researchers have found that Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients.
By Tom Wilemon
1 … 10 11 12 13 14 … 26